A novel serum biomarker quintet reveals added prognostic value when combined with standard clinical parameters in prostate cancer patients by predicting biochemical recurrence and adverse pathology

The objective was to determine the prognostic utility of a new biomarker combination in prostate cancer (PCa) patients undergoing Radical Prostatectomy (RP). Serum samples and clinical data of 557 men who underwent RP for PCa with pathological stage (pT) <3 at Martini Clinic (Hamburg, Germany) we...

Descripción completa

Detalles Bibliográficos
Autores principales: Athanasiou, Alcibiade, Tennstedt, Pierre, Wittig, Anja, Huber, Ramy, Straub, Oliver, Schiess, Ralph, Steuber, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589165/
https://www.ncbi.nlm.nih.gov/pubmed/34767586
http://dx.doi.org/10.1371/journal.pone.0259093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8589165/
https://www.ncbi.nlm.nih.gov/pubmed/34767586
http://dx.doi.org/10.1371/journal.pone.0259093

Ejemplares similares